NCT00176254View on ClinicalTrials.gov

Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Squamous Cell Carcinoma
Interventions
RADIATION

Radiotherapy

80 centigray (cGy) on Day 1 \& 2 and 22 \& 23 of chemotherapy

DRUG

Paclitaxel

225 mg/m2 intravenously over three hours on Days 1 and 22

DRUG

Carboplatin

Area under the curve (AUC) of 6 will be given intravenously over 30 minutes on days 1 and 22

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Susanne Arnold

OTHER